Active in Biological Technology

Human Genome Sciences Reports Positive Long-Term Data for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Patients With Active Systemic Lupus Erythematosus

- Phase 2 continuation data demonstrated sustained improvement in disease activity and patient response rate through four years of BENLYSTA therapy - - Frequency of disease flares as measured by the SELENA SLEDAI flare index and by BILAG A or B organ domain scores decreased over four years o...

The Global Active Pharmaceutical Ingredients (API) Market: A Frost & Sullivan Briefing on Changing Dynamics

LONDON, May 4 /PRNewswire/ -- The Healthcare Group at Frost & Sullivan is pleased to announce its 2009 Quarterly Analyst Briefing Presentation on the Global Active Pharmaceutical Ingredients (API) Market to be held on Wednesday, 6th May 2009, at 3 p.m. GMT. (Logo: http://www.newscom.co...

Bionovo Announces Publication of Data on Active Compound and Mechanism of Action for Its Preclinical Cancer Treatment, BN108

EMERYVILLE, Calif., April 20 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI ) today announced the poster presentation of significant, new data on the nature of the active compound and mechanism of action for its preclinical cancer drug candidate, BN108. The presentation is being made at t...

New Data Suggest CIMZIA(R) (Certolizumab Pegol) Active in Treating Moderate to Severe Crohn's Patients With Fistulizing Disease

Improved outcomes for fistula closures observed in PRECiSE 2 trial under maintenance therapy with stable dosing of CIMZIA(R) every four weeks HOLLYWOOD, Fla., Dec. 5 /PRNewswire-FirstCall/ -- Data presented this week by UCB at Advances in Inflammatory Bowel Diseases 2008, the Crohn's &...

Atrium completes the sale of its Active Ingredients and Specialty Chemicals division

QUEBEC CITY, May 22 /PRNewswire-FirstCall/ - In accordance with the terms previously announced on April 4, 2008, Atrium Innovations Inc. "Atrium" (TSX: ATB) today announced that it has completed the sale of its Active Ingredients and Specialty Chemicals division for total proceeds of US$166.4 ...

Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease

BALTIMORE, May 16 /PRNewswire/ -- Alba Therapeutics Corporation announced today that it has enrolled and randomized its first patient in a twelve-week Phase IIb trial with oral larazotide acetate, an inhibitor of intestinal barrier dysfunction, for the treatment of patients with active celiac ...

Elusys' Anthim(TM) Dramatically Improves Survival of Animals Treated After Active Anthrax Infection

Single, Intramuscular (IM) Dose, Protects up to 75 Percent in Primate Study PINE BROOK, N.J., April 22 /PRNewswire/ -- Elusys Therapeutics, Inc. (Elusys), a privately-held biopharmaceutical company developing antibody-based therapies for the treatment of life-threatening infectious diseases, tod...

UW-Madison associate dean, active in stem cells, leaves

Mulcahy Madison, Wis. The University of Wisconsin-Madison announced on Friday that it will be losing one of its leaders in the field of stem-cell research. R. Timothy Mulcahy, a professor of pharmacology and associate dean of graduate biological studies, will be leaving UW-Madison to become v...

Translate High Yields of Biologically Active Proteins

ActivePro In Vitro Translation Kit Cell-free translation systems are a convenient method for synthesizing proteins in vitro. The major advantages of these in vitro translation systems over conventional in v...

Translate High Yields of Active Protein

ActivePro In Vitro Translation Kit Translation products have higher biological activity than those from other E. coli lysate systems Efficient synthesis of a wide range of prokaryotic...

Rapid PCR* Using Active Tube Temperature Control On Thermo's PCR Machines

Thermo Electron Corporation Solutions Note The time taken to complete a standard PCR protocol is becoming increasingly important for researchers today. Whilst many manufacturers of thermal cyclers focus on pushing the limits of ramp rates, in this article we h...

Highly Active and Removable AffinityTagged Lambda Phosphatase

Dualspecificity Lambda Phosphatase useful for dephosphorylation serine, threonine or tyrosine residues Danny Q. Hoang * Mary Ellen Simcox Stratagene Cloning Systems, Inc. Stratagene's recombinant Lambda Phosphatase is a dualspecificity protein phosphatase that has been produced...

Production of Full-Length, Biologically Active MEK1WT and MEK1CA

Useful tools for signal transduction research and drug screening Quinn Lu Chao-Feng Zheng Stratagene Cloning Systems, Inc. Stratagene has successfully expressed and purified recombinant, wild-type human MEK1 WT and a constitutively active mutant (MEK1 CA ) using the E...

SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results

...ivery platforms are based on multiple issued and pending patents and other intellectual property for the programmed release or enhanced performance of active pharmaceutical ingredients and nutritional products. For more information on SCOLR Pharma, please call 425.368.1050 or visit http://www.scolr.com/ ...

EGEN, Inc. Announces the Promotion of Jason Fewell, Ph.D., to Vice-President of Preclinical Research and Development

...l received his Ph.D. in Biological Science from Florida State University and was a post-doctoral fellow at Cincinnati's Children Hospital. During his active career in research and development, Dr. Fewell has authored numerous scientific publications and is a named inventor on several patents and patent app...

NeurogesX Reports Second Quarter 2009 Results

...d Services (CMS) to discuss U.S. reimbursement. The Company is also evaluating metrics to help size its own U.S. specialty sales force, and remains in active discussions regarding a potential U.S. co-promotion agreement. Anthony DiTonno, President and CEO, commented, "The second quarter of 2009 w...

New clues about a hydrogen fuel catalyst

...oes not remain still, said Rousseau, making it a good catalyst but, like an active two-year old, also a difficult subject to pin down. Plucking Atoms One at a Time The results suggested that the active catalyst picks off hydrogen from a particular spot on the ammonia borane mo...

Exciton Technologies receives FDA approval to market exSALT(TM)

...oating technology utilizing silver oxysalts as the active ingredient. "This achievement represents a signi...n larger market by: - Utilizing a more active form of silver; - Reducing costs; and - ...chemical deposition technique to form a coating of active species of silver on a wide range of materials. Th...

CapitalBio Corporation and VigeneTech Inc. Have Announced the Launch of a Fully Integrated Microarray Solution Platform

...oarray services. Its range of LuxScan(TM) dual and single laser microarray scanners are used widely in Europe, the Americas and Asia. It also develops active biochips and dedicated software for data analysis and biomedical data management. The company, founded in 2000, currently has nearly 400 employees and...

Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Radezolid in Community-Acquired Pneumonia

...iety of Gram-positive organisms; radezolid is also active against linezolid-resistant isolates. Abo...program is developing novel classes of antibiotics active against multi-drug resistant Gram-negative bacteri...gram is focused on developing an IV/oral macrolide active against methicillin-resistant S. aureus , multidr...

Poniard Pharmaceuticals Reports Second Quarter 2009 Financial Results and Provides a Corporate Update

...RPC at the 2009 ASCO Annual Meeting. The updated efficacy and safety data demonstrated that picoplatin in combination with docetaxel and prednisone is active as first-line therapy for metastatic CRPC as demonstrated by several endpoints, including reductions in prostate specific antigen (PSA) levels, diseas...

SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS

...identified more than 250 enhancers of sodium chloride (table salt) that are active in the proprietary screening assays based on SNMX-29, the protein Senomyx b... assay designed to identify potential new cooling agents. Samples that are active in the assay will be evaluated in taste tests to determine their cooling ta...

DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD

...s. orBec((R) )is a highly potent, topically active corticosteroid that has a local effect on inflamed tissue. BDP, the active component of orBec((R)), has been marketed in the ... States and worldwide since the early 1970s as the active pharmaceutical ingredient in inhalation products f...

NovaBay(R) Pharmaceuticals Names Roy J. Wu as Senior Vice President for Business Development

...loping its proprietary and patented Aganocide(R) compounds, which are novel, synthetic anti-infective product candidates that are bioequivalent to the active antimicrobial molecules generated within white blood cells to treat and prevent a wide range of infections without causing bacterial resistance. NovaB...

Hoya Announces First Quarter Financial Results for FY2010

..., Japan, and the leading supplier of innovative and indispensable high-tech products and services based upon its advanced optics technologies. Hoya is active in four fields of business: The Eye Care provides eyeglasses, operates retail shops for contact lenses, and makes intraocular lenses for cataract surg...

Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States

...a sublingual low dose formulation of zolpidem, the active agent most commonly prescribed in the United State...roximately one-quarter to one-third of the dose of active drug contained in currently marketed zolpidem-base...ent seen in these trials was headache (2.7 percent active versus 1.4 percent placebo in the outpatient study...

R-Tech Ueno Notifies R&D Items

...that is, there are currently few therapeutic drugs). 4. Development code RK-023 (dermatological diseases) This item is a physiologically active fatty acid derivative that is a new compound developed by R-Tech Ueno and is being developed as a drug indicated for male pattern alopecia. We intend ...

Transave Enters Into Cooperative Research Agreement With NIH To Study ARIKACE(TM) In Nontuberculous Mycobacteria

...includes thousands of laser drilled holes. Compared to other nebulization technologies, eFlow Technology produces aerosols with a very high density of active drug, a precisely defined droplet size, and a high proportion of respirable droplets delivered in the shortest possible period of time. Combined with ...

Dendreon to Hold Conference Call on Tuesday, August 11, 2009 at 11:30 AM ET

...t and commercialization of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule th...

Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009

...roadest -- and highest quality -- product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's third largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies. For more information, please v...

Neurocrine Biosciences Reports Second Quarter 2009 Results

... (n=174). This study is designed as a randomized, double-blind, placebo and active controlled trial with four treatment arms; elagolix 150 mg, elagolix 250 mg...ot, and placebo. We expect top-line data (first three months of placebo and active controlled treatment) to be available in the fourth quarter of this year. ...

ImmuneRegen BioSciences Confirms Homspera's Therapeutic Anti-Influenza Effect on Pandemic H1N1 Influenza Virus After Oral Administration

...oSciences Holdings, Inc. (OTC Bulletin Board: IRBS), reports preliminary evidence that its selective Neurokinin 1-receptor agonist Homspera(R) is both active on oral administration and provides therapeutic effects against the current pandemic H1N1 virus infection. Preliminary analysis of ongoing bioa...

Sanofi-aventis Announces Second Quarter 2009 Results

...of 2008, when the figures were boosted by sales of active ingredient to our Japanese partners. First-half sa...opean countries, irbesartan is not protected by an active ingredient patent. In the main European countries, Aprovel((R)) is protected by an active ingredient patent through August 2012. Net sales o...

Laureate Pharma Appoints Daniel E. Leone as Vice President of Business Development

...es, Marketing, New Business Development and Supply Chain Management for its active pharmaceutical ingredients business. Prior to BI, Dan held positions of in...n, analytical services, and regulatory support. Laureate is focused on two active segments of the biopharmaceutical industry: monoclonal antibodies and recom...

United States FDA Clears the REGEN Trial to Test Bioheart's Combination Gene and Stem Cell Therapy in Heart Failure Patients

...on product into its FDA-authorized Phase II/III MARVEL study. MyoCell SDF-1 is substantially similar to the original MyoCell composition that has been active in clinical trials since early 2001 at more than 50 centers worldwide. The patents Bioheart has acquired covering the myogenic cells and SDF-1...

Kendle Appoints Stephen Cutler, PhD Senior Vice President and Chief Operating Officer

...ently was Senior Vice President, Global Project Management responsible for the global project management group, including more than 600 people and 500 active projects spanning all therapeutic areas. Previously, he was Senior Vice President, Clinical, Medical and Regulatory, leading more than 1,200 associat...

FluMist(R) Begins Shipping for 2009-2010 Influenza Season

...ble for FluMist. The following people may not be able to get FluMist or may be able to get it only in certain situations: people with asthma or active wheezing, or children less than 5 years of age with recurrent wheezing; people with a history of Guillain-Barre syndrome; people with a weakened immun...

GreenHouse Debuts the World's First E-Fuel MicroFuelerTM in Los Angeles

...roFueler in Los Angeles, GreenHouse is making consumer-use of E-Fuel100 an option for people who want to gain control over vehicle fuel costs and take active steps towards improving the environment," said Ursitti. The E-Fuel MicroFueler system is a model for sustainable energy. It produces organic...

NovaBay(R) Pharmaceuticals to Present at Jesup & Lamont 2009 Growth Stock Conference

...veloping its proprietary and patented Aganocide compounds, which are novel, synthetic, anti-infective product candidates that are bioequivalent to the active antimicrobial molecules generated within white blood cells to treat and prevent a wide range of infections without causing bacterial resistance. NovaB...

Informex Rebrands Into Separate Pharmaceutical and Specialty Chemical Segments to Better Serve Exhibitors and Attendees

...mpanies serving the specialty and industrial chemical markets. Informex Pharma programs will include: * API Pavilion displaying active Pharmaceutical Ingredient companies who service both generic and branded pharmaceuticals. * Pharma Buyer Showcases to allow exhibitors to hear ...